期刊文献+

生长抑素对Oddi括约肌功能的影响 被引量:4

Effect of somatostatin on human sphincter of Oddi motility
暂未订购
导出
摘要 天然生长抑素(somatostatin,SST)是一种胃肠激素及神经肽,主要分布于神经和消化系统中,具有广泛的生物学效应.消化系SST大多由胰腺和胃肠黏膜中的D细胞分泌,能抑制胃肠运动及多种激素分泌.SST调节作用由G蛋白偶联受体,即生长抑素受体(somatostatin receptor,SSTR)介导.Oddi括约肌(sphincter of Oddi,SO)位于十二指肠乳头周围,是一结构和功能相对独立的器官,其运动主要受神经、激素、Cajal间质细胞的调节.SST对SO的作用尚存在争议,本文就生长抑素对SO功能的影响进行综述. Native somatostatin is a gut hormone and neuropeptide, widely distributed in the nervous and gastrointestinal system, and has a broad range of biological actions. In gastrointestinal tract (GIT), somatostatin is mainly produced by the delta cells of the pancreas and gastrointestinal mucosal. The inhibitory effects of somatostatin on gastrointestinal motility and hormone secretion are mediated by a family of G protein-coupled receptors: the somatostatin receptors (SSTR1-5). The sphincter of Oddi (SO) located near the duodenum papillae is an anatomically and functionally distinct organ, SO motility is controlled and regulated by nerve, hormone and interstitial cells of Cajal. The effect of somatostatin on SO motility is still controversial. This article reviewed effect of somatostatin on human sphincter of oddi motility.
作者 周婷 陈明锴
出处 《世界华人消化杂志》 CAS 北大核心 2009年第17期1749-1752,共4页 World Chinese Journal of Digestology
关键词 生长抑素 生长抑素受体 ODDI括约肌 Somatostatin Somatostatin receptor Sphincter of Oddi
  • 相关文献

参考文献33

二级参考文献378

共引文献201

同被引文献45

  • 1彭海峰,郑通标,龚时文,闵军,闫玉矿,段君英.丙谷胺对ERCP术后胰腺功能影响的评价[J].中国医师杂志,2005,7(4):438-440. 被引量:2
  • 2熊光苏,张唏文,吴叔明,戈之铮,莫剑忠.加贝酯预防ERCP术后胰腺炎的临床研究[J].胰腺病学,2005,5(4):200-202. 被引量:9
  • 3胡国潢,段炼,周军,汤恢焕,吕新生.低分子量肝素预防ERCP术后急性胰腺炎的临床研究[J].中国普通外科杂志,2006,15(10):784-787. 被引量:11
  • 4Freeman ML,Disario JA,Nelson DB,et al.Risk factors for post-ERCP pancreatitis:a prospective,multicenter study.Gastrointest Endosc,2001,54:425-434.
  • 5Bai Y,Gao J,Zou DW,et al.Prophylactic octreotide administration does not prevent post-endoscopic retrograde cholangiopancreatography pancreatitis:a meta-analysis of randomized controlled trials.Pancreas,2008,37:241-246.
  • 6Sternlieb JM,Aronchick CA,Retig JN,et al.A multicenter,randomized,controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.Am J Gastroenterol,1992,87:1561-1566.
  • 7Zhang Y,Chen QB,Gao ZY,et al.Meta-analysis:octreotide prevents post-ERCP pancreatitis,but only at sufficient doses.Aliment Pharmacol Ther,2009,29:1155-1164.
  • 8Tsujino T,Komatsu Y,Isayama H,et al.Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography:a randomized,controlled trial.Clin Gastroenterol Hepatol,2005,3:376-383.
  • 9Ueki T,Otani K,Kawamoto K,et al.Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis:a prospective,randomized trial.J Gastroenterol,2007,42:161-167.
  • 10Imamura M,Teshima S,Yamauchi H.Effeets of protease inhibitors on the motor activity of canine sphincter of oddi.Nippon Shokakibyo Gakkai Zasshi,1991,88:2729.

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部